Increased Rac1, Rac2, and, to a lesser extent, Rac3 activity were also observed in primary human CD34+ peripheral blood cells of CML patients and murine p210-BCR-ABL-expressing cells [61]. The gene discussed is RAC2; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.